The epigenetic state of chromatin, gene activity, and chromosomal positions are interrelated. A research team from the IPK ...
Vertex Pharmaceuticals won approval from the U.S. Food and Drug Administration for a non-opioid pain drug, clearing the way for the rollout of a product that has simultaneously sparked high hopes and ...
It’s a new way to create “bi-paternal” mice that can survive to adulthood—but human applications are still a long way off.
The most complex engineering of human cell lines ever has been achieved by scientists, revealing that our genomes are more resilient to significant structural changes than was previously thought.
RFK Jr.'s comments about the gene-editing technology raise a question about how he would regulate it as head of HHS.
Once a week, Sun Kai has a video call with his mother, and they discuss his day-to-day life. But Sun’s mother died five years ...
A £1.65 million treatment has been approved for use for some NHS patients, offering some with an inherited blood disorder ...
Morgan Stanley lowered the firm’s price target on Crispr Therapeutics (CRSP) to $30 from $45 and keeps an Underweight rating on the shares. The ...
Australian researchers have successfully introduced an improved version of Cas12a gene-editing enzyme in mice.
Jim Cramer, the host of Mad Money, reflected on the uncertainty surrounding the year 2025, focusing on several macroeconomic ...
A live webcast of the fireside chat will be available on the "Events & Presentations" page in the Investors section of the Company's website at https://crisprtx.gcs-web.com/events. A replay of the ...